This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Spiller, O. B. Articles by Blackbourn, D. J. Search for Related Content PubMed PubMed Citation Articles by Spiller, O. B. Articles by Blackbourn, D. J.

Complement Regulation by Kaposi's Sarcoma-Associated Herpesvirus ORF4 Protein

Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff CF14 4XX,¹ Division of Virology, Institute of Biomedical and Life Sciences, University of Glasgow,² MRC Virology Unit, Glasgow G11 5JR, United Kingdom³

Received 11 July 2002/ Accepted 30 September 2002

Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with three types of human tumor: Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. The virus encodes a number of proteins that participate in disrupting the immune response, one of which was predicted by sequence analysis to be encoded by open reading frame 4 (ORF4). The predicted ORF4 protein shares homology with cellular proteins referred to as regulators of complement activation. In the present study, the transcription profile of the ORF4 gene was characterized, revealing that it encodes at least three transcripts, by alternative splicing mechanisms, and three protein isoforms. Functional studies revealed that each ORF4 protein isoform inhibits complement and retains a C-terminal transmembrane domain. Consistent with the complement-regulating activity, we propose to name the proteins encoded by the ORF4 gene collectively as KSHV complement control protein (KCP). KSHV ORF4 is the most complex alternatively spliced gene encoding a viral complement regulator described to date. KCP inhibits the complement component of the innate immune response, thereby possibly contributing to the in vivo persistence and pathogenesis of this virus.

This article has been cited by other articles:

• Mark, L., Lee, W. H., Spiller, O. B., Proctor, D., Blackbourn, D. J., Villoutreix, B. O., Blom, A. M. (2004). The Kaposi's Sarcoma-associated Herpesvirus Complement Control Protein Mimics Human Molecular Mechanisms for Inhibition of the Complement System. J. Biol. Chem. 279: 45093-45101 [Abstract] [Full Text]  
• Spiller, O. B., Blackbourn, D. J., Mark, L., Proctor, D. G., Blom, A. M. (2003). Functional Activity of the Complement Regulator Encoded by Kaposi's Sarcoma-associated Herpesvirus. J. Biol. Chem. 278: 9283-9289 [Abstract] [Full Text]